About: Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.01 (+1.62%)
ORMPNASDAQOramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc share price
ORMP price activity
Last Price
$5.010
Change (24hr)
0.08 USD (1.62%)
Volume
226.87K
Volume (4w avg)
-
Open
$4.92
Day Range
$4.86 - $5.05
Previous Close
$4.93
Last Trade
04 Sep, 8:56 pm GMT+0
Delayed
04 Sep, 8:56 pm GMT+0
ORMP price performance
Delayed
04 Sep, 8:56 pm GMT+0
ORMP Market Signals